The 2018–19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe
Restricted accessResearch articleFirst published online January, 2020
The 2018–19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe
The European Collaborative Clinical Group (ECCG) has been surveying clinical management of sexually transmitted infections (STIs) in Europe since its inauguration in 2011. The ECCG is a network of nearly 130 STI specialists from 34 European countries who conduct questionnaire-based research across the European region. The research of ECCG focuses on providing data regarding clinical practice to inform European STI guideline development and revisions. The present paper describes the results of the 2018–19 ECCG survey regarding diagnosis and treatment of gonorrhoea in Europe.
European Centre for Disease Prevention and Control. Gonorrhoea. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC, 2019.
2.
European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe – results summary 2017.
Stockholm:
ECDC, 2019.
3.
TerkelsenDTolstrupJJohnsenCH, et al.
Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill2017;
22: pii=17-00659.
4.
PoncinTFouereSBrailleA, et al.
Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Euro Surveill2018;
23: pii=1800264.
5.
GolparianDRoseLLynamA, et al.
Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill2018;
23: pii=1800617.
6.
EyreDWTownKStreetT, et al.
Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018. Euro Surveill2019;
24: pii=1900147.
7.
EyreDWSandersonNDLordE, et al.
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill2018;
23: ▪.
8.
BignellCUnemoM, on behalf of the European STI Guidelines Editorial Board.
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS2013;
24: 85–92.
FiferHSaundersJSoniS, et al. British Association for Sexual Health and HIV national guidelines for the management of infection with Neisseria gonorrhoeae (2019), https://www.bashhguidelines.org/media/1208/gc-2019.pdf (accessed 9 August 2019).
11.
Centers for Disease Control and Prevention.
Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;
64: 1–137.
12.
BignellCFitzgeraldM, Guideline Development GROUP;
British Association for Sexual Health and HIV UK. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS2011;
22: 541–547.
13.
UnemoMClarkeEBoikoI, et al. Adherence to the ‘2012 European guideline on the diagnosis and treatment of gonorrhoea in adults’ in WHO European Region according to the 2018–19 IUSTI ECCG Gonorrhoea Survey data. Int J STD AIDS.
